1,087
Views
12
CrossRef citations to date
0
Altmetric
Food & Nutrition Science

Yamogenin in fenugreek inhibits lipid accumulation through the suppression of gene expression in fatty acid synthesis in hepatocytes

, , , , , , , , & show all
Pages 1231-1236 | Received 03 Feb 2014, Accepted 13 Feb 2014, Published online: 17 Jun 2014

References

  • Kahn BB, Flier JS. Obesity and insulin resistance. J. Clin. Invest. 2000;106:473–481.10.1172/JCI10842
  • Lewis GF, Carpentier A, Adeli K, Adria K. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 2002;23:201–229.10.1210/edrv.23.2.0461
  • Roepstorff C, Halberg N, Hillig T, Saha AK, Ruderman NB, Wojtaszewski JF, Richter EA, Kiens B. Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. Am. J. Physiol. Endocrinol. Metab. 2005;288:133–142.
  • Tugwood JD, Issemann I, Anderson RG, Bundell KR, McPheat WL, Green S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 1992;11:433–439.
  • Chen G, Liang G, Ou J, Goldstein JL, Brown MS. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc. Natl. Acad. Sci. USA, 2004;101:11245–11250.10.1073/pnas.0404297101
  • Edwards PA, Kast HR, Anisfeld AM. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J. Lipid Res. 2002;43:2–12.
  • Brown MS, Goldstein JL. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc. Natl. Acad. Sci. USA, 1999;96:11041–11048.10.1073/pnas.96.20.11041
  • Morton JF. Mucilaginous plants and their uses in medicine. J. Ethnopharmacol. 1990;29:215–266.
  • Basch E, Ulbricht C, Kuo G, Szapary P, Smith M. Therapeutic applications of fenugreek. Altern. Med. Rev. 2003;8:20–27.
  • Trinh HT, Han SJ, Kim SW, Lee YC, Kim DH. Bifidus fermentation increases hypolipidemic and hypoglycemic effects of red ginseng. J. Microbiol. Biotechnol. 2007;17:1127–1133.
  • Li H, Wang QJ, Zhu DN, Yang Y. Reinioside C, a triterpene saponin of Polygala aureocauda Dunn, exerts hypolipidemic effect on hyperlipidemic mice. Phytother. Res. 2008;22:159–164.10.1002/(ISSN)1099-1573
  • Uemura T, Goto T, Kang MS, Mizoguchi N, Hirai S, Lee JY, Nakano Y, Shono J, Hoshino S, Tsuge N, Narukami T, Makishima M, Takahashi N, Kawada T. Diosgenin, the main aglycon of fenugreek, inhibits LXRα activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese diabetic mice. J. Nutr. 2011;141:17–23.10.3945/jn.110.125591
  • Kim IL, Hirai S, Takahashi H, Goto T, Ohyane C, Tsugane T, Konishi C, Fujii T, Inai S, Iijima Y, Aoki K, Shibata D, Takahashi N, Kawada T. 9-oxo-10(E),12(E)-Octadecadienoic acid derived from tomato is a potent PPAR α aganist to decrease triglyceride accumulation in mouse primary hepatocytes. Mol. Nutr. Food Res. 2011;55:585–593.10.1002/mnfr.v55.4
  • Takahashi N, Kawada T, Yamamoto T, Goto T, Taimatsu A, Aoki N, Kawasaki H, Taira K, Yokoyama KK, Kamei Y, Fushiki T. Overexpression and ribozyme-mediated targeting of transcriptional coactivators CREB-binding protein and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 2002;277:16906–16912.10.1074/jbc.M200585200
  • Takahashi N, Kawada T, Goto T, Yamamoto T, Taimatsu A, Kimura K, Saitoh M, Hosokawa T, Miyashita K, Fushiki T. Dual action of isoprenols from herbal medicines on both PPARgamma and PPARalpha in 3T3-L1 adipocytes and HepG2 hepatocytes. FEBS Lett. 2002;514:315–322.10.1016/S0014-5793(02)02390-6
  • Taylor WG, Elder JL, Chang PR, Rixhards KW. Microdetermination of diosgenin from fenugreek (Trigonella foenum-graecum) seeds. J. Agric. Food Chem. 2000;48:5206–5210.10.1021/jf000467t
  • Carroll VM, Jeyakumar M, Carlson KE, Katzenellenbogen JA. Diarylpropionitrile (DPN) enantiomers: synthesis and evaluation of estrogen receptor β-selective ligands. J. Med. Chem. 2012;55:528–537.10.1021/jm201436k
  • Pochetti G, Godio C, Mitro N, Caruso D, Galmozzi A, Scurati S, Loiodice F, Fracchiolla G, Tortorella P, Laghezza A, Lavecchia A, Novellino E, Mazza F, Crestani M. Insights into the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligands. J. Biol. Chem. 2007;282:17314–17324.10.1074/jbc.M702316200
  • Ying M, Stephenson CRJ, Kendall C, Saini SPS, Toma D, Ren S, Cai H, Strom SC, Day BW, Wipf P, Xie W. A pregnane X receptor agonist with unique species-dependent stereoselectivity and its implications in drug development. Mol. Pharmacol. 2005;68:403–413.
  • Brand W, Shao J, Hoek-van den Hil EF, van Elk KN, Spenkelink B, de Haan LH, Rein MJ, Dionisi F, Williamson G, van Bladeren PJ, Rietjens IM. Stereoselective conjugation, transport and bioactivity of s- and R-hesperetin enantiomers in vitro. J. Agric. Food Chem. 2010;58:6119–6125.
  • Horton JD, Goldstein JL, Brown MS. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J. Clin. Invest. 2002;101:2331–2339.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.